Julia Pike

Julia Pike serves as the Global Head of Intellectual Property at Sandoz, holding the position since May 2009. In this role, Julia leads teams in Princeton, New Jersey, and Boucherville, Canada, overseeing all patent litigation and freedom-to-operate for a diverse product portfolio. Notably, Julia spearheaded a landmark litigation that facilitated the entry of Sandoz's first biosimilar, Zarxio, into the US market. Additionally, Julia has established a global IP litigation function within Sandoz and advocated for sustainable generic business models in Europe while serving as the European Public Affairs Director. Prior experience includes leadership roles at Hospira, Inc., Mayne Pharma Limited, and Corrs Chambers Westgarth. Julia holds a Master's of Law in Intellectual Property and a Bachelor of Science/Law from the University of Melbourne.